NIH pumps $1.14M into Texas Heart Institute to develop life-saving cardiatric drug - InnovationMap
The Texas Heart Institute announced that it had received a two-year, $1.14 million grant from The National Heart, Lung, and Blood Institute to develop a novel, first-in-class drug to treat the cardiovascular disease that arises from atherosclerosis.| InnovationMap
